Rosario García-Campelo

Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial

Tina Cascone, Gozde Kar, Jonathan Spicer et al. · Cancer Discovery · 2023 · 117 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy

Marta Casarrubios, Mariano Provencio, Ernest Nadal et al. · Journal for ImmunoTherapy of Cancer · 2022 · 62 citations · Full text

Medicine, Immunology, Oncology +17

Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial

Raquel Laza‐Briviesca, Alberto Cruz‐Bermúdez, Ernest Nadal et al. · Clinical and Translational Medicine · 2021 · 56 citations · Full text

Medicine, Immunology, Oncology +17

SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)

Rosario García-Campelo, Ivana Sullivan, Edurne Arriola et al. · Clinical & Translational Oncology · 2023 · 32 citations · Full text

Medicine, Cancer Biology, Oncology +17

Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial

Tina Cascone, Laura Bonanno, Florian Guisier et al. · Nature Medicine · 2025 · 24 citations · Full text

Medicine, Oncology, Pharmacotherapy +17